中西医结合治疗溃疡性结肠炎的疗效及安全性

张可训

（陕西省三原县医院，陕西 咸阳，713800）

浏览次数：123次 下载次数：349次

摘要：

目的 探究中西医结合治疗溃疡性结肠炎的疗效及安全性。方法 将我院2014年3月至2017年2月收治的90例溃疡 性结肠炎患者作为研究对象，随机分成试验组与对照组，各45例。对照组患者仅给予常规西医治疗，试验组采取中西医结合 治疗。比较分析两组患者的治疗效果及不良反应发生情况。结果 试验组患者治疗总有效率为88.89%，明显高于对照组的 62.22%（P<0.05）；治疗后，试验组的不良反应总发生率为17.78%，明显低于对照组的40.00%，差异具有统计学意义（P<0.05）。结论 中西医结合治疗在溃疡性结肠炎治疗中具有重要作用，可有效地提高患者治疗总有效率，降低不良反应总发生率，安 全性较高，值得使用与推广。

关键词：中西医结合；溃疡性结肠炎；安全性

中图分类号：R574.62 文献标志码：A文章编号：2096-1413(2018)02-0122-02

Efficacy and safety of integrated traditional Chinese and western medicine in the treatment of ulcerative colitis
ZHANG Ke-xun
(the Hospital of Sanyuan County, Xianyang 713800, China)

ABSTRACT: Objective To investigate the efficacy and safety of integrated traditional Chinese and western medicine in the treatment of ulcerative colitis. Methods Ninety patients with ulcerative colitis treated in our hospital from March 2014 to February 2017 were enrolled as the objects, and randomly divided into experimental group and control group, with 45 cases in each group. Patients in the control group were given conventional western medicine treatment, and the experimental group was treated with traditional Chinese and western medicine treatment. The efficacy and adverse reactions of the two groups were compared and analyzed. Results The total effective rate of the experimental group was 88.89%, which was significantly higher than 62.22% of the control group (P<0.05). After treatment, the total incidence of adverse reactions in
the experimental group was 17.78%, which was significantly lower than 40.00% in the control group, the difference was statistically significant (P<0.05). Conclusion Integrated traditional Chinese and western medicine in the treatment of ulcerative colitis has an important role, which can effectively improve the total effective rate and decrease the total incidence of adverse reactions, with high safety. It is worth using and promoting.
KEYWORDS: integrated traditional Chinese and western medicine; ulcerative colitis; safety

参考文献：
[1] 郭海军.观察分析评价中西医结合治疗溃疡性结肠炎的临床疗效[J].世界最新医学信息文摘,2016,16(A5):163,168.
[2] 朱颖玲,唐晓华,吴红铃.中西医结合疗法治疗溃疡性结肠炎的疗效及对凝血功能、炎性因子水平的影响分析[J].中国医药科学,2016,6(23):82-86.
[3] 杨梦.重度溃疡性结肠炎的中西医结合治疗与单纯西医治疗的临床疗效对比分析[J].中医临床研究,2015,7(14):94-95.
[4] 冯德魁,黄少鹏,贾恒,等.中西医结合治疗湿热内蕴型溃疡性结肠炎的临床疗效观察[J].广州中医药大学学报,2015,32(2):243-246.
[5] 贾思荣.中西医结合治疗溃疡性结肠炎的疗效观察及作用机制探讨[J].泰山医学院学报,2015,36(10):1138-1140.
[6] GREEN JR,SWAN CH,GIBSON JA,et al.Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational study[J].Aliment Pharmacol Ther,2015,19(4):435-442.
[7] 陈建辉.中西医结合治疗溃疡性结肠炎的临床疗效观察[J].现代医 药卫生,2015,31(3)：415-416.
[8] 崔刚.中西医结合治疗49 例溃疡性结肠炎的疗效观察[J].中国医 药指南,2013,11(3):256-257.
[9] SONG YN,ZHENG P.Efficacy and safety of tumor necrosis factor-α blockers for ulcerative colitis: a systematic review and meta-analysis of published randomized controlled trials [J ].J Food Drug Anal, 2015,23(1):1-10.
[10] CHHAYA V,SAXENA S,CECIL E,et al.The impact of timing and duration of thiopurine treatment on colectomy in ulcerative colitis: a national population-based study of incident cases between 1989 -2009[J].Aliment Pharmacol Ther,2015,41(1):87-98.